EUVIMEDOdkrijte EUVIMED
Open access · CC BY 4.0

Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines

Brittany P Rickard iD, Lauren A Sapienza-Lundie, Marta Overchuk, Xianming Tan iD, Victoria L Bae-Jump, Melinda S Yates, Suzanne E Fenton, Imran Rizvi iD

Photochemistry and Photobiology · 2025

DOI: 10.1111/php.14073 ↗

At a glance

Journal article in Photochemistry and Photobiology, 2025. Written by Brittany P Rickard and 7 co-authors. Institution: Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA. Major MEDLINE topics: Endometrial Neoplasms, Drug Resistance, Neoplasm, Photosensitizing Agents, Carboplatin. Cited 3 times so far (Crossref); 80 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIEHS NIH HHS, University of North Carolina, National Institutes of Health/National Cancer Institute.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

First‐line treatment for advanced‐stage or recurrent endometrial cancer consists of platinum‐ and taxane‐based chemotherapy, to which many patients will develop resistance. Determining the factors that contribute to platinum resistance and developing alternate treatment options for patients with advanced‐stage gynecologic malignancies is critical to improving survival outcomes. Recently, we published the first study evaluating the contribution of perfluoroalkyl substances (PFAS) exposure to platinum resistance in endometrial cancer cell lines and found that select PFAS induce carboplatin resistance, potentially by dysregulating mitochondrial function. The present study expands upon those findings by examining the efficacy of photodynamic priming (PDP) in combination with carboplatin to overcome PFAS‐induced platinum resistance. Due to the suspected role of mitochondrial dysfunction in platinum resistance, two clinically approved photosensitizers that, in part, localize to mitochondrial membranes or are synthesized in mitochondria were evaluated: benzoporphyrin derivative (BPD) and aminolevulinic acid‐induced protoporphyrin IX (ALA‐PpIX), respectively. Combination of ALA‐PpIX‐mediated PDP + carboplatin resulted in a greater reduction in survival fraction than the same combination with BPD. While PDP with both photosensitizers reduced mitochondrial membrane potential, the reduction was greater with BPD‐PDP than ALA‐PpIX‐PDP. These findings demonstrate that BPD‐PDP and ALA‐PpIX‐PDP in combination with carboplatin can be used to overcome PFAS‐induced platinum resistance in endometrial cancer cells.

Subjects

MeSH terms (MEDLINE)

Endometrial NeoplasmsDrug Resistance, NeoplasmPhotosensitizing AgentsCarboplatinPhotochemotherapyFluorocarbonsAntineoplastic AgentsPlatinumHumansFemaleCell Line, Tumor

Author keywords

PDTPFASendometrial cancerphotodynamic primingplatinum resistance

Substances

Photosensitizing AgentsCarboplatinFluorocarbonsAntineoplastic AgentsPlatinum

Authors and institutions

  • Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.
  • Curriculum in Toxicology and Environmental Medicine, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Lampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
  • Department of Biostatistics, University of North Carolina School of Public Health, Chapel Hill, North Carolina, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

ORCID profiles: Brittany P Rickard, Xianming Tan, Imran Rizvi

Funding

  • NIEHS NIH HHS
  • University of North Carolina
  • National Institutes of Health/National Cancer Institute
  • NCI NIH HHS
  • NIH HHS
  • National Institute of Environmental Health Sciences
  • National Institutes of Health

Cite

APA

Rickard, B. P., Sapienza-Lundie, L. A., Overchuk, M., Tan, X., Bae-Jump, V. L., Yates, M. S., Fenton, S. E., & Rizvi, I. (2025). Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines. Photochemistry and Photobiology. https://doi.org/10.1111/php.14073

Vancouver

Rickard BP, Sapienza-Lundie LA, Overchuk M, Tan X, Bae-Jump VL, Yates MS, et al. Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines. Photochemistry and Photobiology. 2025. doi:10.1111/php.14073

BibTeX
@article{Rickard2025,
  author = {Rickard, Brittany P and Sapienza-Lundie, Lauren A and Overchuk, Marta and Tan, Xianming and Bae-Jump, Victoria L and Yates, Melinda S and Fenton, Suzanne E and Rizvi, Imran},
  title = {Photodynamic priming overcomes platinum resistance from short‐term exposure to select perfluoroalkyl substances in endometrial cancer cell lines},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  doi = {10.1111/php.14073}
}
Start for free →